Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Unraveling the Evolutionary Paths in Relapsed Early-Stage Follicular Lymphoma Showing Complete Remission

Jasmine Makker, Andrew Wotherspoon, Maria-Myrsini Tzioni, Zi Chen, Francesco Cucco, Ming-Qing Du

Blood (2023) 142 (Supplement 1): 5733.

https://doi.org/10.1182/blood-2023-178237

Published: 2023

Journal Articles

EBV + diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant–related lymphomas

Lénaïg Mescam, Vincent Camus, Jean-Marc Schiano, José Adélaïde, Jean-Michel Picquenot, Arnaud Guille, Marie Bannier, Philippe Ruminy, Pierre-Julien Viailly, Fabrice Jardin, Reda Bouabdallah, Isabelle Brenot-Rossi, Elodie Bohers, Cyrielle Robe, Camille Laurent, Daniel Birnbaum, Andrew Wotherspoon, Philippe Gaulard, Luc Xerri

Blood (2020) 135 (22): 2004–2009.

https://doi.org/10.1182/blood.2019003408

Published: 2020

Includes: Supplemental data

Journal Articles

Splenic Marginal Zone Lymphoma: Risk of Transformation, Clinico-Biological Features at Transformation and Prognosis

Blood (2019) 134 (Supplement_1): 4015.

https://doi.org/10.1182/blood-2019-127199

Published: 2019

Journal Articles

Durable Remissions Achieved with R-CHOP Chemotherapy without Radiotherapy in Patients with Primary Mediastinal B-Cell Lymphoma - the Royal Marsden Experience

Vasiliki Michalarea, MD, Dima El-Sharkawi, MBBS BSc FRCPath MD, Siraj Yusuf, Mary Gleeson, Laura Hickmott, Andrew Wotherspoon, Ayoma Attygalle, Simon O'Connor, Bhupinder Sharma, Yong Du, Imene Zerizer, Alan Horwich, Gillian Ross, Andrea Kuhnl, Sunil Iyengar, Ian Chau, MD, David Cunningham

Blood (2018) 132 (Supplement 1): 4240.

https://doi.org/10.1182/blood-2018-99-119560

Published: 2018

Journal Articles

R-GEM-Lenalidomide Versus R-GEM-P As Second-Line Treatment of Diffuse Large B-Cell Lymphoma: Results from the UK NCRI Phase II Randomized Legend Trial

Andrea Kuhnl, MD, Clare Peckitt, Bijal Patel, Kirit M Ardeshna, MD, Marian P Macheta, John Radford, MD, Rod Johnson, Shankaranarayana Paneesha, Sarah Barton, Ian Chau, MD, Martin F Kaiser, MD, Ruwaida Begum, Nicola Valeri, Andrew Wotherspoon, Yong Du, Imene Zerizer, David Cunningham, MD FRCP

Blood (2017) 130 (Supplement 1): 2829.

https://doi.org/10.1182/blood.V130.Suppl_1.2829.2829

Published: 2017

Journal Articles

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Charlotte Wilding, BSc, MBChB, Farheen Mir, MBBS, Indu Mitra, Bhupinder Sharma, Larissa Sena, Andrew Wotherspoon, David Cunningham, MD FRCP, Ian Chau, MD, Claire E. Dearden, MD FRCP, FRCPath, Kabir Mohammed, Sunil Iyengar

Blood (2017) 130 (Supplement 1): 2786.

https://doi.org/10.1182/blood.V130.Suppl_1.2786.2786

Published: 2017

Journal Articles

Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations

Blood (2017) 129 (8): 1042–1045.

https://doi.org/10.1182/blood-2016-11-751024

Published: 2017

Includes: Supplemental data

Journal Articles

Improved Survival in Peripheral T-Cell Lymphoma (PTCL) Following Complete Response to First-Line Chemotherapy: 10 Year Experience at the Royal Marsden and the Christie Hospitals 2002-2012

Blood (2015) 126 (23): 1499.

https://doi.org/10.1182/blood.V126.23.1499.1499

Published: 2015

Journal Articles

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

Mary Gleeson, FRCPath, Eliza A Hawkes, MD, Clare Peckitt, MSc, Andrew Wotherspoon, FRCPath, Ayoma Attygalle, PhD, Bhupinder Sharma, MD, Yong Du, MD, Mark Ethell, MD, Michael Potter, PhD, Claire Dearden, MD, Alan Horwich, MD, Ian Chau, MD, David Cunningham, FMedSci

Blood (2014) 124 (21): 1719.

https://doi.org/10.1182/blood.V124.21.1719.1719

Published: 2014

Journal Articles

Gene Expression Profiling Classifies Splenic Marginal Zone Lymphoma and Hairy Cell Leukemia-Variant as Related Diseases That Are Distinct From Typical Hairy Cell Leukemia.

Sarah L Hockley, PhD, Alison Morilla, Andrew Wotherspoon, MD, PhD, Brian A Walker, PhD, Nicholas J Dickens, PhD, Daniel Catovsky, MD, DSc(Med), Gareth J Morgan, MD, PhD, Estella Matutes, MD, PhD, David Gonzalez, PhD

Blood (2009) 114 (22): 3467.

https://doi.org/10.1182/blood.V114.22.3467.3467

Published: 2009

Journal Articles

CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment

Piers E. M. Patten, Andrea G. S. Buggins, Julie Richards, Andrew Wotherspoon, Jon Salisbury, Ghulam J. Mufti, Terry J. Hamblin, Stephen Devereux

Blood (2008) 111 (10): 5173–5181.

https://doi.org/10.1182/blood-2007-08-108605

Published: 2008

Journal Articles

Correlation between TP53 Deletion and Protein Overexpression in Chronic Lymphocytic Leukaemia and Its Impact on Prognostic.

Paloma Martin, Toon Min, Alison Morilla, Sarah Hockley, Ayoma D. Attygale, John Swansbury, Claire Dearden, Andrew Wotherspoon, Gareth Morgan, Estella Matutes

Blood (2007) 110 (11): 2076.

https://doi.org/10.1182/blood.V110.11.2076.2076

Published: 2007

Journal Articles

CD38 Expression in B-CLL Is Dynamic and Changes Due to Contact with Activating Stimuli Found within the Leukaemic Microenvironment.

Piers E.M. Patten, MD, Andrea G.S. Buggins, PhD, Julie Richards, PhD, Andrew Wotherspoon, MD, Terry John Hamblin, MD, Ghulam Mufti, MD, Stephen Devereux, MD PhD

Blood (2006) 108 (11): 2798.

https://doi.org/10.1182/blood.V108.11.2798.2798

Published: 2006

Journal Articles

High Grade Transformation in Splenic Marginal Zone Lymphoma: A Description of a Series of 8 Cases.

Moez R. Dungarwalla, MBBS, MRCP, DipRCPath, Andrew Wotherspoon, Gareth Morgan, Daniel Catovsky, Claire E. Dearden, Estella Matutes

Blood (2006) 108 (11): 4599.

https://doi.org/10.1182/blood.V108.11.4599.4599

Published: 2006

Journal Articles

B- Cell Chronic Lymphocytic Leukaemia Complicated by Aggressive T-Cell Lymphoma: Clinical and Molecular Analysis of a Rare Variant of Richter’s Syndrome.

Ferdinandos Skoulidis, MRCP, Kevin Boyd, MRCP, David Cunningham, MD, FRCP, Andrew Wotherspoon, MRCPath, David Gonzalez, PhD, Daniel Catovsky, MD, FRCP, FRCPath, Gareth Morgan, FRCP, PhD, FRCPath, Estella Matutes, MD, PhD, Claire Dearden, MD, FRCP, MRCPath

Blood (2005) 106 (11): 4999.

https://doi.org/10.1182/blood.V106.11.4999.4999

Published: 2005

Journal Articles

Use of Gemcitabine, Cisplatin and Methylprednisolone (GEM-P) with or without Rituximab in Relapsed and Refractory Patients with Diffuse Large B Cell Lymphoma (DLBCL).

Bhawna Sirohi, David Cunningham, Andy Norman, Michele Trumper, Sheela Rao, Tracey Murray, Yvonne Prior, Geoffrey Chong, Kim Last, Andrew Wotherspoon

Blood (2005) 106 (11): 939.

https://doi.org/10.1182/blood.V106.11.939.939

Published: 2005

Journal Articles

B- Prolymphocytic Leukemia Shows Heterogeneous IgVH Mutational Status and Expression of ZAP-70 and CD38.

Ilaria Del Giudice, Zadie Davis, Nnenna Osuji, Nilima Parry-Jones, Estella Matutes, Vasantha Brito-Babapulle, Andrew Wotherspoon, David Oscier, Daniel Catovsky

Blood (2004) 104 (11): 2004.

https://doi.org/10.1182/blood.V104.11.2004.2004

Published: 2004

Journal Articles

High incidence of t(11;18)(q21;q21) in Helicobacter pylori –negative gastric MALT lymphoma

Hongtao Ye, Hongxiang Liu, Markus Raderer, Andreas Chott, Agnes Ruskone-Fourmestraux, Andrew Wotherspoon, Martin J. S. Dyer, Shih-Sung Chuang, Ahmet Dogan, Peter G. Isaacson, Ming-Qing Du

Blood (2003) 101 (7): 2547–2550.

https://doi.org/10.1182/blood-2002-10-3167

Published: 2003

Journal Articles

Molecular follow-up in gastric mucosa–associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial

Francesco Bertoni, Annarita Conconi, Carlo Capella, Teresio Motta, Roberto Giardini, Maurilio Ponzoni, Ennio Pedrinis, Domenico Novero, Paolo Rinaldi, Giovanni Cazzaniga, Andrea Biondi, Andrew Wotherspoon, Barry William Hancock, Paul Smith, Robert Souhami, Finbarr E. Cotter, Franco Cavalli, Emanuele Zucca

Blood (2002) 99 (7): 2541–2544.

https://doi.org/10.1182/blood.V99.7.2541

Published: 2002

NARROW

Unraveling the Evolutionary Paths in Relapsed Early-Stage Follicular Lymphoma Showing Complete Remission

EBV + diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant–related lymphomas

Splenic Marginal Zone Lymphoma: Risk of Transformation, Clinico-Biological Features at Transformation and Prognosis

Durable Remissions Achieved with R-CHOP Chemotherapy without Radiotherapy in Patients with Primary Mediastinal B-Cell Lymphoma - the Royal Marsden Experience

R-GEM-Lenalidomide Versus R-GEM-P As Second-Line Treatment of Diffuse Large B-Cell Lymphoma: Results from the UK NCRI Phase II Randomized Legend Trial

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations

Improved Survival in Peripheral T-Cell Lymphoma (PTCL) Following Complete Response to First-Line Chemotherapy: 10 Year Experience at the Royal Marsden and the Christie Hospitals 2002-2012

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

Gene Expression Profiling Classifies Splenic Marginal Zone Lymphoma and Hairy Cell Leukemia-Variant as Related Diseases That Are Distinct From Typical Hairy Cell Leukemia.

CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment

Correlation between TP53 Deletion and Protein Overexpression in Chronic Lymphocytic Leukaemia and Its Impact on Prognostic.

CD38 Expression in B-CLL Is Dynamic and Changes Due to Contact with Activating Stimuli Found within the Leukaemic Microenvironment.

High Grade Transformation in Splenic Marginal Zone Lymphoma: A Description of a Series of 8 Cases.

B- Cell Chronic Lymphocytic Leukaemia Complicated by Aggressive T-Cell Lymphoma: Clinical and Molecular Analysis of a Rare Variant of Richter’s Syndrome.

Use of Gemcitabine, Cisplatin and Methylprednisolone (GEM-P) with or without Rituximab in Relapsed and Refractory Patients with Diffuse Large B Cell Lymphoma (DLBCL).

B- Prolymphocytic Leukemia Shows Heterogeneous IgVH Mutational Status and Expression of ZAP-70 and CD38.

High incidence of t(11;18)(q21;q21) in Helicobacter pylori –negative gastric MALT lymphoma

Molecular follow-up in gastric mucosa–associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only